Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor–Positive Advanced Breast Cancer Malignant pleural effusion (MPE) is common in ...
PTS-500 is under clinical development by Gongwin Biopharm and currently in Phase II for Malignant Pleural Effusion.